Our data confirm the possible role of afamin in evaluating diabetes complications, being elevated in DN subjects, but reduced in both DC and NC subjects, indicating that elevated levels could predict the future progression of diabetes-related cardiovascular disease. Here, AFM is linked to cardiovascular disorder.